{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:09:12Z","timestamp":1789189752226,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jmoldx.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T19:06:21Z","timestamp":1700507181000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Utility and Reimbursement of Next-Generation Sequencing\u2013Based Testing for Myeloid Malignancies"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-1786","authenticated-orcid":false,"given":"Craig R.","family":"Soderquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Leeman-Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate C.","family":"Stutzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Sigcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Alobeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-1904","authenticated-orcid":false,"given":"Helen","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh M.","family":"Mansukhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-4969","authenticated-orcid":false,"given":"Susan J.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2023.09.012_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcancer.2021.03.034","article-title":"Precision medicine in myeloid malignancies","volume":"84","author":"Westermann","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/biomedicines11020641","article-title":"Targeted therapy development in acute myeloid leukemia","volume":"11","author":"Totiger","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib6","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib7","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/leu.2014.125","article-title":"ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients","volume":"28","author":"Patnaik","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib8","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jmoldx.2021.07.010","article-title":"Validation, implementation, and clinical impact of the oncomine myeloid targeted-amplicon DNA and RNA ion semiconductor sequencing assay","volume":"23","author":"Ferrone","year":"2021","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13000-016-0456-8","article-title":"Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms","volume":"11","author":"Au","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bjh.14269","article-title":"Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera","volume":"175","author":"Delic","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2016-10-745273","article-title":"Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy","volume":"129","author":"Duncavage","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.2021011323","article-title":"Relationship between clone metrics and clinical outcome in clonal cytopenia","volume":"138","author":"Galli","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib15","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/bloodadvances.2022008578","article-title":"Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions","volume":"7","author":"DeZern","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1182\/blood.2019000942","article-title":"Genetics of progression from MDS to secondary leukemia","volume":"136","author":"Menssen","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15099","article-title":"Clonal evolution in myelodysplastic syndromes","volume":"8","author":"da Silva-Coelho","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2015-11-679167","article-title":"Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure","volume":"128","author":"Mossner","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib19","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41375-020-0997-4","article-title":"Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)","volume":"35","author":"Yun","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.2019004770","article-title":"Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia","volume":"135","author":"Hasserjian","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib22","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/bloodadvances.2022009564","article-title":"Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms","volume":"7","author":"Nannya","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.2019003988","article-title":"Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib24","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41375-021-01153-0","article-title":"Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia","volume":"35","author":"Rapaport","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100020","article-title":"Insurance denials and diagnostic rates in a pediatric genomic research cohort","volume":"25","author":"Zion","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41436-020-01081-x","article-title":"Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics","volume":"23","author":"Smith","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jgc4.1543","article-title":"Utilization of genetic testing: analysis of 4,499 prior authorization requests for molecular genetic tests at four US regional health plans","volume":"31","author":"Bajguz","year":"2022","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jmoldx.2023.09.012_bib28","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/cncr.34271","article-title":"State legislative trends related to biomarker testing","volume":"128","author":"Sadigh","year":"2022","journal-title":"Cancer"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823002635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823002635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:18:03Z","timestamp":1761502683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157823002635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1525157823002635"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.09.012","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Utility and Reimbursement of Next-Generation Sequencing\u2013Based Testing for Myeloid Malignancies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}